February 08, 2026 02:48 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Namaste Trump beat Howdy Modi’: Congress slams PM Over India-US trade deal | Historic India-US trade pact: Tariffs cut, $500B market opportunity unlocked! | Big call from RBI: Repo rate stays at 5.25%, neutral stance continues | RG Kar scam twist: Court issues non-bailable warrant against whistle-blower Akhtar Ali | Court snub for Vijay: Madras HC rejects plea in ₹1.5 crore tax case | ‘We never said no’: Suryakumar Yadav says India ready for Pakistan clash at T20 World Cup | Supreme Court orders Mamata govt to clear pending dues | ‘India is free to buy oil from anyone’: Russia fires back at Trump’s crude deal claim | ‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming
Nepal
Image: Wikimedia Commons

Russia’s Sputnik-V given conditional approval in Nepal

| @indiablooms | Apr 21, 2021, at 10:58 pm

As Nepal struggles to procure vaccines from India, authorities in Nepal have given emergency use approval to Russia’s Sputnik-V Covid-19 vaccines, as per a report in the Kathmandu Post.

In a meeting on Tuesday, Nepal’s Department of Drug Administration decided to issue a conditional emergency use authorization to the vaccine, a statement released by the body says.

The approval came at a time when the South Asia region is witnessing a renewed wave across all its countries. So far, the government has given emergency use approvals to four vaccines.

“The company had applied for emergency use approval through the local supplier in Nepal, “ Santosh KC, the spokesperson for the department, was quoted as saying by The Kathmandu Post. “Based on the data provided by the suppliers of the company, we have given a conditional emergency use authorization,” he added.

The existing cold storage infrastructure in the country is sufficient for Sputnik-V which is required to be stored between 2 to 8-degree celsius. The Sputnik V vaccine’s efficacy is reported at 91.6 percent.

So far, around 1.8 million people have been vaccinated with Covishield while around 100,000 with Chinese Sinopharm. The government has already made an advance 80 percent payment to India SII for 5 million doses of Covishield. However, the SII is unlikely to supply any doses in the next one and half months.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.